Tarsus Pharmaceuticals Inc (TARS)

Feb 20, 2025

Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

When Will Tarsus Share Its Latest Financial Performance? Key Date Revealed - StockTitan

Feb 20, 2025

Feb 19, 2025

Allspring Global Investments Holdings LLC Lowers Stock Position in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Feb 19, 2025

Feb 19, 2025

Allspring Global Investments Holdings LLC Has $10.03 Million Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Feb 19, 2025

Feb 15, 2025

5,825 Shares in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Acquired by Bleakley Financial Group LLC - MarketBeat

Feb 15, 2025

Feb 14, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Feb 14, 2025

Feb 14, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by abrdn plc - MarketBeat

Feb 14, 2025

Feb 13, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Receives "Buy" Rating from Guggenheim - MarketBeat

Feb 13, 2025

Feb 13, 2025

Where Are They Now? Tarsus Pharmaceuticals - Life Science Leader Magazine

Feb 13, 2025

Feb 12, 2025

A Bill Maher joke spotlighted Tarsus Pharmaceuticals’ crust mite fight - MM+M Online

Feb 12, 2025

Feb 12, 2025

Bleakley Financial Group LLC Purchases Shares of 5,825 Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Feb 12, 2025

Feb 12, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Average Recommendation of “Buy” by Brokerages - Defense World

Feb 12, 2025

Feb 11, 2025

Tarsus Pharmaceuticals’ (TARS) “Buy” Rating Reaffirmed at Guggenheim - Defense World

Feb 11, 2025

Feb 10, 2025

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Shares Sold by SG Americas Securities LLC - Defense World

Feb 10, 2025

Feb 09, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Reaches New 12-Month HighShould You Buy? - MarketBeat

Feb 09, 2025

Feb 08, 2025

Long Term Trading Analysis for (TARS) - news.stocktradersdaily.com

Feb 08, 2025

Feb 08, 2025

E. Ohman J or Asset Management AB Lowers Holdings in Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Feb 08, 2025

Feb 07, 2025

Is Tarsus Pharmaceuticals (NASDAQ:TARS) Using Too Much Debt? - Simply Wall St

Feb 07, 2025

Feb 07, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Down 5.3%What's Next? - MarketBeat

Feb 07, 2025

Feb 07, 2025

Tarsus Pharmaceuticals Inc (TARS) Stock: Navigating Drops and Gains - The InvestChronicle

Feb 07, 2025

Feb 07, 2025

Tarsus Pharmaceuticals Inc (TARS) Shares Down Despite Recent Market Volatility - The News Heater

Feb 07, 2025

Feb 06, 2025

Jennison Associates LLC Acquires 321,552 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - MarketBeat

Feb 06, 2025

Feb 06, 2025

Janney Montgomery Scott LLC Sells 2,218 Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Defense World

Feb 06, 2025

Feb 04, 2025

Strong Growth Prospects and Market Expansion Drive Buy Rating for Tarsus Pharmaceuticals - TipRanks

Feb 04, 2025

Feb 04, 2025

Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Yahoo Finance

Feb 04, 2025

Feb 03, 2025

BofA Adjusts Price Target on Tarsus Pharmaceuticals to $75 From $74 -February 03, 2025 at 10:36 am EST - Marketscreener.com

Feb 03, 2025

Jan 30, 2025

Tarsus to Participate in Upcoming Investor Conferences - GlobeNewswire

Jan 30, 2025

Jan 30, 2025

Exclusive Access: Tarsus Pharma's Double-Header at Elite Healthcare Investment Forums - StockTitan

Jan 30, 2025

Jan 30, 2025

Tarsus to Participate in Upcoming Investor Conferences -January 30, 2025 at 05:00 pm EST - Marketscreener.com

Jan 30, 2025

Jan 28, 2025

How To Trade (TARS) - Stock Traders Daily

Jan 28, 2025

Jan 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Up 9% After Analyst Upgrade - Defense World

Jan 28, 2025

Jan 28, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Given New $62.00 Price Target at Barclays - Defense World

Jan 28, 2025

Jan 27, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading 9% Higher After Analyst Upgrade - MarketBeat

Jan 27, 2025

Jan 27, 2025

A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts - Benzinga

Jan 27, 2025

Jan 27, 2025

Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $62.00 at Barclays - MarketBeat

Jan 27, 2025

Jan 25, 2025

Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential - MSN

Jan 25, 2025

Jan 25, 2025

Tarsus Pharmaceuticals Inc (NASDAQ: TARS): An Enticing Stock To Watch - Stocks Register

Jan 25, 2025

Jan 24, 2025

Midday Stock Roundup: Virgin Galactic down 2.3% and 87% YoY - Orange County Business Journal

Jan 24, 2025

Jan 23, 2025

Tarsus: Promising Investment, But Timing Is The Key (NASDAQ:TARS) - Seeking Alpha

Jan 23, 2025

Jan 23, 2025

Oppenheimer Increases Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target to $72.00 - MarketBeat

Jan 23, 2025

Jan 22, 2025

First Week of TARS March 21st Options Trading - Nasdaq

Jan 22, 2025

Jan 21, 2025

Tarsus PharmaceuticalEye Care Therapeutics - MSN

Jan 21, 2025

Jan 20, 2025

Is Tarsus Pharmaceuticals (TARS) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - Insider Monkey

Jan 20, 2025